AVADEL PHARMACEUTICALS PLC

Avadel Pharmaceuticals PLC

Drug Manufacturers - Specialty & Generic • Healthcare • Dublin, Ireland • AVDL (NGM)

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.

353 1 901 5201 10 Earlsfort Terrace, Ireland

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Morgan Stanley discloses trades in Avadel Pharmaceuticals shares - Investing.com
Investing.com • Dec 29
Assessing Avadel Pharmaceuticals (AVDL) Valuation After Strong 1-Year Share Price Performance - Yahoo Finance
Yahoo Finance • Dec 20
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Investing.com • Dec 29
Avadel Pharmaceuticals PLC. $AVDL Shares Sold by Squarepoint Ops LLC - MarketBeat
MarketBeat • Dec 21
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc - PR Newswire
PR Newswire • Oct 22

Other Drug Manufacturers - Specialty & Generic Companies

View All →
Elanco Animal Health Inc logo Elanco Animal Health Inc.
1 layoff tracked
$11.23B market cap
Zoetis Inc. logo Zoetis Inc.
$55.83B market cap
Galderma Group AG/ADR logo Galderma Group AG
$49.28B market cap
TAKEDA PHARMACEUTICAL CO LTD logo Takeda Pharmaceutical Co. Ltd.
$47.02B market cap
Haleon plc logo Haleon PLC
$44.93B market cap
TEVA PHARMACEUTICAL INDUSTRIES LTD logo TEVA Pharmaceutical Industries Ltd.
$32.82B market cap

Frequently Asked Questions

Has AVADEL PHARMACEUTICALS PLC had layoffs?
No layoff events have been recorded for AVADEL PHARMACEUTICALS PLC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does AVADEL PHARMACEUTICALS PLC have?
AVADEL PHARMACEUTICALS PLC has approximately 188 employees.
What industry is AVADEL PHARMACEUTICALS PLC in?
AVADEL PHARMACEUTICALS PLC operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is AVADEL PHARMACEUTICALS PLC a publicly traded company?
Yes, AVADEL PHARMACEUTICALS PLC is publicly traded under the ticker symbol AVDL on the NGM. The company has a market capitalization of approximately $2.12 billion.
Where is AVADEL PHARMACEUTICALS PLC headquartered?
AVADEL PHARMACEUTICALS PLC is headquartered in Dublin, Ireland at 10 Earlsfort Terrace, Ireland.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.